Email this article Clinical manifestations of endocrine orbitopathy in patients with autoantibodies to tireoperoksidaze vehicles
- Issue: Vol 19, No 3 (2011)
- Pages: 69-74
- Section: Articles
- URL: https://journals.rcsi.science/pavlovj/article/view/5023
- DOI: https://doi.org/10.17816/PAVLOVJ2011369-74
- ID: 5023
Cite item
Full Text
Abstract
The authors conducted a comparative analysis of clinical manifestations of endocrine orbitopathy in patients with Graves disease, depending on whether the presence of antibodies to tireoperoksidaze and their absence. The paper presents direct evidence to show that the persistence of autoantibodies to tireoperoksidaze endocrine orbitopathy affecting clinical manifestations. The Group of patients living with antibodies to SLIP more expressed above proptosis, eyelid edema and oculomotor disorders. Clinical evidence substantiated mul′tispiral′ computed tomography.
Full Text
##article.viewOnOriginalSite##References
- Антитела к рецептору ТТГ как предикторы тяжести и исходов эндокринной офтальмопатии у пациентов с болезнью Грейвса / Н.Ю. Свириденко [и др.] // Пробл. эндокринологии. – 2011. – В печати.
- Табеева К.И. Клиническое течение эндокринной офтальмопатии после хирургического лечения болезни Грейвса: автореф. дис. канд. мед. наук / К.И. Табеева. – М., 2010.
- Шеремета М.С. Эндокринная офтальмопатия: диагностика, особенности течения после радиойодтерапии болезни Грейвса: автореф. дис. канд. мед. наук / М.С. Шеремета. – М., 2011.
- Bahn R.S. Pathogenesis of Graves ophthalmopathy: the role of orbital thyroid-stimulating hormone receptor expression / R.S. Bahn // Current Opinion in Endocrinology & Diabetes. – 2003 – Vol. 10, Is. 5. – Р. 353-356.
- Thyrotropin Receptor Autoantibodies Are Independent Risk Factors for Graves' Ophthalmopathy and Help to Predict Severity and Outcome of the Disease / A.K. Eckstein [et al.] // J. Clin. Endocrinol. Metab. – 2006. – Vol. 91. – Р. 3464-3470.
- Thyroid autoantibody profiles in ophthalmic dominant and thyroid dominant Graves' disease differ and suggest ophthalmopathy is a multiantigenic disease / S.Y. Goh [et al.] // Clinical Endocrinology. – 2004. – Vol. 60, № 5. – Р. 600-607.
- Graves orbitopathy / eds.: W.M. Wiersinga, G.J. Kahaly. – Basel: KARGER, 2007. – 260 p.
- Khoo T.K. Pathogenesis of Graves’ ophthalmopathy: the role of autoantibodies / T.K. Khoo, R.S. Bahn // Thyroid. – 2007. – Vol. 17, № 10. – P. 1013-1008.
- Clinical consequences of activating germline mutations of TSH receptor, the concept of toxic hyperplasia / J. Leclere [et al.] // Horm Res. – 1997. – Vol. 47, № 4-6. – P. 158-162.
- Changes in serum TSH-receptor antibody values i n patients with Graves’ Disease after total or subtotal thyroidectomy / Y. Takamura [et al.] // Endocrinol Journ. – 2003. – Vol. 50, №5. – P. 595-601.
Supplementary files
